Kingston General Hospital

Kingston, Ontario

We've found

1 trials

at this facility

Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Kingston,

Use our guide to learn which trials are right for you!